713 related articles for article (PubMed ID: 34297653)
21. THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar.
Qoronfleh MW; Chouchane L; Mifsud B; Al Emadi M; Ismail S
Life Sci Soc Policy; 2020 Nov; 16(1):12. PubMed ID: 33129349
[TBL] [Abstract][Full Text] [Related]
22. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
23. Disruptive innovations for designing and diffusing evidence-based interventions.
Rotheram-Borus MJ; Swendeman D; Chorpita BF
Am Psychol; 2012 Sep; 67(6):463-76. PubMed ID: 22545596
[TBL] [Abstract][Full Text] [Related]
24. Analysis of adoption rates for Needs Driven versus Value Driven innovation water technologies.
O'Callaghan P; Adapa LM; Buisman C
Water Environ Res; 2019 Feb; 91(2):144-156. PubMed ID: 30735298
[TBL] [Abstract][Full Text] [Related]
25. Next-Generation Sequencing Informatics: Challenges and Strategies for Implementation in a Clinical Environment.
Roy S; LaFramboise WA; Nikiforov YE; Nikiforova MN; Routbort MJ; Pfeifer J; Nagarajan R; Carter AB; Pantanowitz L
Arch Pathol Lab Med; 2016 Sep; 140(9):958-75. PubMed ID: 26901284
[TBL] [Abstract][Full Text] [Related]
26. Health Technology Assessment for Cardiovascular Digital Health Technologies and Artificial Intelligence: Why Is It Different?
Vervoort D; Tam DY; Wijeysundera HC
Can J Cardiol; 2022 Feb; 38(2):259-266. PubMed ID: 34461229
[TBL] [Abstract][Full Text] [Related]
27. Automation and artificial intelligence in the clinical laboratory.
Naugler C; Church DL
Crit Rev Clin Lab Sci; 2019 Mar; 56(2):98-110. PubMed ID: 30922144
[TBL] [Abstract][Full Text] [Related]
28. Orde ab Chao Method for Disruptive Innovations Creation (With COVID-19 Pandemic Case Application).
Likar B; Trcek D
Front Psychol; 2020; 11():581968. PubMed ID: 33643108
[TBL] [Abstract][Full Text] [Related]
29. Insights from semi-structured interviews on integrating artificial intelligence in clinical chemistry laboratory practices.
Jafri L; Farooqui AJ; Grant J; Omer U; Gale R; Ahmed S; Khan AH; Siddiqui I; Ghani F; Majid H
BMC Med Educ; 2024 Feb; 24(1):170. PubMed ID: 38389053
[TBL] [Abstract][Full Text] [Related]
30. Consolidation of Clinical Microbiology Laboratories and Introduction of Transformative Technologies.
Vandenberg O; Durand G; Hallin M; Diefenbach A; Gant V; Murray P; Kozlakidis Z; van Belkum A
Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102900
[TBL] [Abstract][Full Text] [Related]
31. Future of Health Services: The Role of Physicians in the Disruptive Era.
Wiweko B; Zakirah SC
J Hum Reprod Sci; 2020; 13(4):250-256. PubMed ID: 33627972
[TBL] [Abstract][Full Text] [Related]
32. Evolution of Business Models in Regenerative Medicine: Effects of a Disruptive Innovation on the Innovation Ecosystem.
Banda G; Tait J; Mittra J
Clin Ther; 2018 Jul; 40(7):1084-1094. PubMed ID: 30017170
[TBL] [Abstract][Full Text] [Related]
33. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
[TBL] [Abstract][Full Text] [Related]
34. Innovation in patient-centered care: lessons from a qualitative study of innovative health care organizations in Washington State.
Reed P; Conrad DA; Hernandez SE; Watts C; Marcus-Smith M
BMC Fam Pract; 2012 Dec; 13():120. PubMed ID: 23241305
[TBL] [Abstract][Full Text] [Related]
35. Blazing the trail for innovative tuberculosis diagnostics.
Yerlikaya S; Broger T; Isaacs C; Bell D; Holtgrewe L; Gupta-Wright A; Nahid P; Cattamanchi A; Denkinger CM
Infection; 2024 Feb; 52(1):29-42. PubMed ID: 38032537
[TBL] [Abstract][Full Text] [Related]
36. Disrupting the infectious disease ecosystem in the digital precision health era innovations and converging emerging technologies.
Abbo LM; Vasiliu-Feltes I
Antimicrob Agents Chemother; 2023 Oct; 67(10):e0075123. PubMed ID: 37724872
[TBL] [Abstract][Full Text] [Related]
37. Disruptive business value models in the digital era.
Sewpersadh NS
J Innov Entrep; 2023; 12(1):2. PubMed ID: 36686335
[TBL] [Abstract][Full Text] [Related]
38. A survey on Artificial Intelligence and Big Data utilisation in Italian clinical laboratories.
Bellini C; Padoan A; Carobene A; Guerranti R
Clin Chem Lab Med; 2022 Nov; 60(12):2017-2026. PubMed ID: 36067004
[TBL] [Abstract][Full Text] [Related]
39. Start-Up's Road to Disruptive Innovation in the Digital Era: The Interplay Between Dynamic Capabilities and Business Model Innovation.
Zhang K; Feng L; Wang J; Qin G; Li H
Front Psychol; 2022; 13():925277. PubMed ID: 35800925
[TBL] [Abstract][Full Text] [Related]
40. A Structured Pathway Toward Disruption: A Novel HealthTec Innovation Design Curriculum With Entrepreneurship in Mind.
Fritzsche H; Barbazzeni B; Mahmeen M; Haider S; Friebe M
Front Public Health; 2021; 9():715768. PubMed ID: 34540788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
